7,761,403 Shares in Alignment Healthcare, Inc. $ALHC Bought by William Blair Investment Management LLC

William Blair Investment Management LLC bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,761,403 shares of the company’s stock, valued at approximately $184,799,000.

Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Alignment Healthcare by 10.9% during the fourth quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock worth $305,983,000 after purchasing an additional 1,524,218 shares during the last quarter. Wellington Management Group LLP increased its position in shares of Alignment Healthcare by 26.9% during the 4th quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock valued at $277,900,000 after purchasing an additional 2,981,166 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its position in shares of Alignment Healthcare by 0.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock valued at $249,715,000 after purchasing an additional 79,268 shares during the last quarter. Invesco Ltd. increased its position in shares of Alignment Healthcare by 38.9% during the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after purchasing an additional 1,735,962 shares during the last quarter. Finally, 8 Knots Management LLC raised its holdings in shares of Alignment Healthcare by 6.4% during the 2nd quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock valued at $70,222,000 after buying an additional 300,409 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock opened at $13.16 on Friday. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. The business’s 50 day simple moving average is $18.84 and its two-hundred day simple moving average is $18.83. The stock has a market capitalization of $2.73 billion, a P/E ratio of 69.27 and a beta of 1.10. Alignment Healthcare, Inc. has a one year low of $12.70 and a one year high of $25.12.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.04. The firm had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.31 billion. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The business’s revenue was up 31.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.07 earnings per share. Analysts forecast that Alignment Healthcare, Inc. will post 0.17 EPS for the current year.

Wall Street Analyst Weigh In

ALHC has been the subject of a number of recent research reports. TD Cowen restated a “buy” rating on shares of Alignment Healthcare in a research report on Monday, August 3rd. Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Barclays decreased their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. JPMorgan Chase & Co. lowered their price objective on shares of Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, August 4th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Alignment Healthcare in a research note on Tuesday, August 4th. Seven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average price target of $23.60.

Insider Buying and Selling

In related news, insider Hyong Kim sold 35,951 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $19.86, for a total transaction of $713,986.86. Following the completion of the sale, the insider directly owned 331,750 shares in the company, valued at $6,588,555. This represents a 9.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Joseph S. Konowiecki sold 25,000 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $24.00, for a total transaction of $600,000.00. Following the sale, the executive vice president directly owned 1,103,816 shares of the company’s stock, valued at $26,491,584. The trade was a 2.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,009,951 shares of company stock valued at $18,597,287 over the last quarter. Company insiders own 5.20% of the company’s stock.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.